跳至主要内容
临床试验/NCT02860845
NCT02860845已完成4 期

Multicenter Pilot Study to Compare the Efficacy of a Combination of Vaginal Capsules With Acid Boric, L.Gasseri and L.Rhamnosus Versus the Reference Medication in Patients With Vaginal Candidiasis or Bacterial Vaginosis

Laboratorios Ordesa1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2016年7月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
Change in the Presence of Vaginitis Clinical Symptoms Determined by Sobel Score.

研究概览

简要总结

The purpose of this study is to determine whether a formula of boric acid and probiotics for vaginal application is effective in the treatment of symptomatic episodes of vulvovaginitis in comparison to pharmacological reference controls (depending on the suspected diagnosis).

详细描述

Multicentre, Open, Prospective, Randomized, Controlled. Women with suspected vaginal infection will be randomized and distributed into two groups (control or boric acid + probiotics). Follow-up will last for three months and consists in 3 visits and a telephone interview.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age over 18 years and agreement to participate by signing the consent form.
  • Women with clinical manifestations of acute infectious vulvovaginitis (burning, pruritus, erythema, oedema, and abnormal vaginal discharge).

排除标准

  • Clinical findings compatible with Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis infection.
  • Use of anti-fungal, antibiotic or probiotic medication within last 2 weeks prior to the study.
  • Patients receiving other treatment (drug, probiotics or vitamin supplements) that can significantly interfere with study evaluations during the 3 months of follow-up.
  • Pregnant or high risk for pregnancy.

研究组 & 干预措施

Boric acid and probiotics

Experimental

Boric acid with L.gasseri and L.rhamnosus

干预措施: Boric acid and probiotics (Device)

Antibiotic/Antifungal

Active Comparator

Antibiotic: Clindamicine Antifungal: Clotrimazol

干预措施: Antibiotic (Clindamycin) (Drug)

Antibiotic/Antifungal

Active Comparator

Antibiotic: Clindamicine Antifungal: Clotrimazol

干预措施: Antifungal (Clotrimazole) (Drug)

结局指标

主要结局

Change in the Presence of Vaginitis Clinical Symptoms Determined by Sobel Score.

时间窗: Baseline and at 2 weeks after treatment finalization

Semi-quantitative scale where itching, erythema, edema, stinging and abnormal vaginal discharge are scored from 0 to 3: absent (0), mild (1), moderate (2), severe (3). Worse result is 3 (severe)

次要结局

  • Change in the Level of Lactobacillus in Vaginal Flora Determined by Vaginal Cultures.(Baseline and 2 weeks after treatment finalization)
  • Number of Participants With Recurrent Infections(At 3 months after recruitment)

研究者

发起方
Laboratorios Ordesa
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Use of Boric Acid in Combination With Probiotics for... | 临床试验